The FDA Is Finally Writing Rules for AI on the Pharma Factory Floor
A new item on CDER's 2026 guidance agenda, 'AI/ML Quality Considerations in Pharmaceutical Manufacturing,' aims to set validation and audit-trail standards for…
Clinical AI, digital care and the systems patients actually encounter.
A new item on CDER's 2026 guidance agenda, 'AI/ML Quality Considerations in Pharmaceutical Manufacturing,' aims to set validation and audit-trail standards for…
The deal with Iambic Therapeutics targets cancer, digestive and immune diseases, and follows a wave of multibillion-dollar AI biotech partnerships from AstraZeneca,…
With a global caregiver shortage projected to top 10 million workers by 2030, remote patient monitoring platforms are using AI to catch…
A Blue Cross Blue Shield Association analysis ties $942 million in added spending over two years to AI-assisted coding, setting up what…
Roughly half of American adults take a daily supplement. In 2026, researchers made real progress on whether multivitamins work, even as federal…
Hospitals, insurers, clinicians and the software now sitting between them.